Afebrile benign convulsions with or without a reversible splenial lesion in two pediatric patients with COVID-19.
BMC Pediatr
; 23(1): 198, 2023 04 26.
Article
in English
| MEDLINE | ID: covidwho-2298622
ABSTRACT
BACKGROUND:
Seizures in children with coronavirus disease 2019 (COVID-19) were markedly increased during the Omicron variant surge. Most seizures occurred with fever. New-onset afebrile seizures were rarely reported; therefore, their courses are not well-known. CASE PRESENTATION Two patients (7 and 26 months of age, respectively) with COVID-19 showed recurrent afebrile seizures immediately after resolution of a fever lasting for 2-3 days. Bilateral convulsive seizures lasted for approximately 1 min/episode (6 of 7 total episodes) and occurred 3-4 times within 2-3 h. However, the patients were alert between seizures, which is in contrast to seizures occurring with encephalopathy or encephalitis. Only one episode required acute antiseizure medication. Brain magnetic resonance imaging showed a reversible splenial lesion in one patient. The serum uric acid level was slightly increased (7.8 mg/dL) in this patient. Electroencephalography findings were all normal. During the follow-up period, no seizures or developmental problems have been observed.CONCLUSIONS:
COVID-19-associated, afebrile benign convulsions with or without a reversible splenial lesion are similar to 'benign convulsions with mild gastroenteritis'; therefore, continuation of antiseizure medication does not seem necessary.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Uric Acid
/
COVID-19
Type of study:
Case report
/
Cohort study
/
Prognostic study
Topics:
Long Covid
/
Variants
Limits:
Child
/
Humans
/
Infant, Newborn
Language:
English
Journal:
BMC Pediatr
Journal subject:
Pediatrics
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS